What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
His scientific interests lie mostly in Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Coronary artery disease.
His Internal medicine study combines topics from a wide range of disciplines, such as Positron emission tomography and Endocrinology.
His work on Cardiology is being expanded to include thematically relevant topics such as Interquartile range.
The various areas that Hans Erik Bøtker examines in his Myocardial infarction study include Position paper and Hazard ratio.
His work investigates the relationship between Percutaneous coronary intervention and topics such as Angioplasty that intersect with problems in ST elevation.
His Coronary artery disease study integrates concerns from other disciplines, such as Non cardiac surgery, Fractional flow reserve, Stenosis, Radiology and Dobutamine stress echocardiography.
His most cited work include:
- 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (871 citations)
- Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial (786 citations)
- Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). (758 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Percutaneous coronary intervention are his primary areas of study.
Hans Erik Bøtker has researched Internal medicine in several fields, including Endocrinology and Surgery.
His Cardiology research incorporates elements of Diabetes mellitus and Angiography.
His Myocardial infarction research incorporates themes from Stroke, Randomized controlled trial and Hazard ratio.
His work carried out in the field of Coronary artery disease brings together such families of science as Computed tomography angiography, Radiology, Stenosis, Chest pain and Risk factor.
His study looks at the relationship between Percutaneous coronary intervention and fields such as Stent, as well as how they intersect with chemical problems.
He most often published in these fields:
- Internal medicine (76.11%)
- Cardiology (60.53%)
- Myocardial infarction (35.01%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (76.11%)
- Cardiology (60.53%)
- Myocardial infarction (35.01%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and In patient.
His research in Internal medicine intersects with topics in Diabetes mellitus and Endocrinology.
His Cardiology study combines topics in areas such as Angiography, Disease and Confidence interval.
He studies Myocardial infarction, namely Percutaneous coronary intervention.
His work in Percutaneous coronary intervention addresses subjects such as Stent, which are connected to disciplines such as Target lesion.
His study in Coronary artery disease is interdisciplinary in nature, drawing from both Computed tomography angiography, Fractional flow reserve, Stenosis, Chest pain and Risk factor.
Between 2017 and 2021, his most popular works were:
- Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. (194 citations)
- Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. (191 citations)
- Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial (96 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
